Convergys (CVG) Touches $24.44 Formed H&S; ABATTIS BIOCEUTICALS ORDINARY SHAR (ATTBF) Shorts Decreased By 97.45%

Abattis Bioceuticals Corp. (OTCMKTS:ATTBF) Logo

Convergys Corporation (CVG) formed inverse H&S with $26.15 target or 7.00% above today’s $24.44 share price. Convergys Corporation (CVG) has $2.24B valuation. The stock decreased 3.67% or $0.93 during the last trading session, reaching $24.44. About 5.14M shares traded or 481.69% up from the average. Convergys Corporation (NYSE:CVG) has declined 0.75% since June 30, 2017 and is downtrending. It has underperformed by 13.32% the S&P500. Some Historical CVG News: 11/05/2018 – Convergys Is in Talks With Several Potential Buyers; 16/05/2018 – Convergys sees limited interest in second round; 08/05/2018 – Convergys 1Q Adj EPS 41c; 11/05/2018 – CONVERGYS IS IN TALKS WITH SEVERAL POTENTIAL BUYERS – WSJ, CITING; 20/04/2018 – DJ Convergys Corporation, Inst Holders, 1Q 2018 (CVG); 16/04/2018 – Convergys Accelerates Deployment of Robotic Process Automation (RPA) to More Than One-Third of its Workforce to Streamline Performance and Simplify Customer Interactions; 08/05/2018 – Convergys Raises Quarter Dividend to 11c; 08/05/2018 – CONVERGYS 1Q ADJ EPS CONT OPS 41C, EST. 40C; 10/04/2018 – Convergys Closes Above 50-Day Moving Average: Technicals; 16/05/2018 – Convergys sees limited interest in second round, sources say [14:49 BST16 May 2018] [Proprietary] []

ABATTIS BIOCEUTICALS CORP ORDINARY SHAR (OTCMKTS:ATTBF) had a decrease of 97.45% in short interest. ATTBF’s SI was 4,500 shares in June as released by FINRA. Its down 97.45% from 176,500 shares previously. The stock decreased 1.35% or $0.001752 during the last trading session, reaching $0.128248. About 533,366 shares traded. Abattis Bioceuticals Corp. (OTCMKTS:ATTBF) has 0.00% since June 30, 2017 and is . It has underperformed by 12.57% the S&P500.

Since March 5, 2018, it had 0 insider buys, and 2 selling transactions for $777,901 activity. Greenwald Taylor C sold $80,488 worth of stock or 3,399 shares. Another trade for 30,000 shares valued at $697,413 was made by Ayers Andrea J. on Monday, March 5.

Among 3 analysts covering Convergys Corp (NYSE:CVG), 0 have Buy rating, 0 Sell and 3 Hold. Therefore 0 are positive. Convergys Corp had 4 analyst reports since January 25, 2018 according to SRatingsIntel. The rating was maintained by Robert W. Baird on Thursday, January 25 with “Hold”. Citigroup maintained Convergys Corporation (NYSE:CVG) rating on Friday, June 29. Citigroup has “Neutral” rating and $26.5 target. The firm has “Hold” rating by Robert W. Baird given on Thursday, February 22.

Analysts await Convergys Corporation (NYSE:CVG) to report earnings on August, 14. They expect $0.36 earnings per share, down 21.74% or $0.10 from last year’s $0.46 per share. CVG’s profit will be $32.94M for 16.97 P/E if the $0.36 EPS becomes a reality. After $0.41 actual earnings per share reported by Convergys Corporation for the previous quarter, Wall Street now forecasts -12.20% negative EPS growth.

Investors sentiment increased to 1.06 in 2018 Q1. Its up 0.06, from 1 in 2017Q4. It improved, as 22 investors sold Convergys Corporation shares while 80 reduced holdings. 35 funds opened positions while 73 raised stakes. 90.38 million shares or 1.74% more from 88.84 million shares in 2017Q4 were reported. Fuller Thaler Asset Mngmt Inc invested 1.06% of its portfolio in Convergys Corporation (NYSE:CVG). Teachers Retirement Sys Of The State Of Kentucky stated it has 19,437 shares or 0.01% of all its holdings. Leuthold Grp Ltd Liability Corporation holds 80,284 shares or 0.21% of its portfolio. 48,631 were reported by Zebra Cap Llc. Sei owns 241 shares or 0% of their US portfolio. Moreover, Macquarie Gp Ltd has 0.03% invested in Convergys Corporation (NYSE:CVG). Gargoyle Inv Advisor Ltd Co owns 45,746 shares or 0.42% of their US portfolio. Bluemountain Management Lc owns 10,004 shares. Moreover, Signaturefd Limited Liability Company has 0% invested in Convergys Corporation (NYSE:CVG) for 813 shares. Deutsche National Bank & Trust Ag has 473,171 shares for 0.01% of their portfolio. Colorado-based Employees Retirement Association Of Colorado has invested 0% in Convergys Corporation (NYSE:CVG). Engineers Gate Manager L P owns 84,229 shares. Saturna Cap holds 351,383 shares or 0.25% of its portfolio. Alliancebernstein Limited Partnership holds 0% or 210,093 shares. Nomura stated it has 149,338 shares.

Abattis Bioceuticals Corp., a biotechnology company, develops, licenses, and markets health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets in Canada. The company has market cap of $49.54 million. It is also involved in the possession of cannabis and related active ingredients, as well as the production of extracts; and bioceutical marketing services in the area of health products. It currently has negative earnings. The firm was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corp. in September 2012.

Convergys Corporation (NYSE:CVG) Institutional Positions Chart